Form CERTNAS - Certification by the Nasdaq Stock Market approving securities for listing:
SEC Accession No. 9999999997-14-013150
Filing Date
2014-08-28
Accepted
2014-08-29 14:22:53
Documents
1
Effectiveness Date
2014-08-28

Document Format Files

Seq Description Document Type Size
1 AUTO-GENERATED PAPER DOCUMENT 9999999997-14-013150.paper CERTNAS 294
  Scanned paper document scanned.pdf   38469
  Complete submission text file 9999999997-14-013150.txt   1300
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

EIN.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: CERTNAS | Act: 34 | File No.: 001-36421 | Film No.: 14007909
SIC: 2834 Pharmaceutical Preparations